Skip to main content
https://pbs.twimg.com/media/FZQGgPDXkAEsZ-m.jpg
Plasmacytoid Dendritic Cell Inhibitor in Cutaneous Lupus Litifilimab, a humanized monoclonal antibody against BDCA2, targets the BDCA2 receptor on plasmacytoid dendritic cells. https://t.co/qOu2jMa6EK https://t.co/LMaY7gpt05
Dr. John Cush
03-08-2022
×